top of page


Taking the same care of your deal as you do of your clients

If you are considering an exit, the timing is right to capitalise on ongoing investment in the Healthcare & Pharmaceuticals sector.

Part of what makes Britain Great is our National Health Service.  And the NHS and the community in turn is served by many privately owned businesses.  Medical Supplies & Technology, Domiciliary Care, Pharmacies, Life Sciences, Specialist Communications & Technology and many more businesses like yours make up this eco-system, generating the sustainable returns on which the continued strength of the sector depends.

The outlook for M&A in the Healthcare & Pharmaceuticals sector is positive. With total UK health spending in excess of £200 billion per year, it's not hard to see why. Government health service budget holders and General Practices are seeking ever more innovative ways to enhance the quality of the care they provide and the services they run.

At Symmetry, we know that it is imperative that you achieve maximum value for any investment or company sale and we know just how to achieve that for you. We generate reliable, dynamic & confidentiality controlled market & bid processes to put you in a position to choose your purchaser on the basis of strategic fit as well as optimum price & terms.

Crucially, we make sure purchasers and capital investors understand what makes our client's individual businesses special. Where you have Intellectual Property and market advantage that will have even greater value under new ownership, we know just how to leverage that so you can be sure your deal won't be restricted by narrow accounting methods.

Contact us today for a free, no obligation consultation to discuss how to maximise the value of your business.

bottom of page